Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
23 studies found for:    Open Studies | "Bile Duct Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours
Condition: Bile Duct Cancer
Interventions: Drug: GEMCIS;   Drug: mFolfirinox
2 Recruiting Single Agent Regorafenib in Refractory Advanced Biliary Cancers
Condition: Cancer of the Bile Duct
Intervention: Drug: Regorafenib
3 Not yet recruiting Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Conditions: Bile Duct Cancer;   Intrahepatic Cholangiocarcinoma
Interventions: Combination Product: Melphalan/HDS;   Drug: Cisplatin and Gemcitabine
4 Not yet recruiting Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
Conditions: Biliary Obstructive Disease Such as Choledocholithiasis;   Benign Biliary Stricture;   Peri-ampullary Cancer;   Bile Duct Cancer Resectable;   Klatskin Tumor
Interventions: Biological: Pacetin® (cefoxitin);   Biological: Placebo
5 Recruiting Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Conditions: Cholangiocarcinoma;   Tumor;   Klatskin Tumor
Intervention: Drug: Temoporfin
6 Recruiting Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
Conditions: Carcinoma of Intrahepatic and Extra-hepatic Biliary System;   Carcinoma of Gallbladder;   Bile Duct Cancer;   Cholangiocarcinoma
Interventions: Drug: DKN-01;   Drug: gemcitabine;   Drug: cisplatin
7 Recruiting CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
8 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
9 Recruiting Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy
Conditions: Pancreatic Cancer;   Bile Duct Cancer;   Duodenal Cancer
Interventions: Procedure: PrPD with proximal Roux-en-y gastrojejunal anastomosis;   Procedure: conventional PrPD
10 Not yet recruiting Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Conditions: Non-Resectable Cholangiocarcinoma;   Recurrent Cholangiocarcinoma;   Stage III Extrahepatic Bile Duct Cancer;   Stage III Intrahepatic Cholangiocarcinoma;   Stage IIIA Hilar Cholangiocarcinoma;   Stage IIIB Hilar Cholangiocarcinoma;   Stage IVA Extrahepatic Bile Duct Cancer;   Stage IVA Hilar Cholangiocarcinoma;   Stage IVA Intrahepatic Cholangiocarcinoma;   Stage IVB Extrahepatic Bile Duct Cancer;   Stage IVB Hilar Cholangiocarcinoma;   Stage IVB Intrahepatic Cholangiocarcinoma;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Ricolinostat
11 Recruiting Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy
Conditions: Gastric Cancer;   Pancreas Cancer;   Bile Duct Cancer;   Gastroesophageal Cancer
Interventions: Behavioral: Early Palliative Care visit;   Other: EORTC-QLQ-C30 questionnaire;   Other: HADS score
12 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
13 Not yet recruiting The Effect of Individualized Precision Therapy Programs in Patients With BTC
Condition: Biliary Tract Neoplasms
Intervention: Other: Individualized Precision Therapy Programs
14 Recruiting Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
Conditions: Cholangiocarcinoma;   Pancreatic Cancer;   Bile Duct Cancer;   Biliary Stricture;   Bile Duct Obstruction
Intervention: Device: Radio Frequency ablation Probe
15 Recruiting Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Lung Cancer;   Melanoma;   Non-Hodgkin's Lymphoma;   Uterine Cancer;   CORPUS UTERI,ENDOMETRIUM;   LUNG;   OVARY
Intervention:
16 Not yet recruiting Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
Condition: Biliary Tract Cancer
Interventions: Drug: Varlitinib;   Drug: Capecitabine;   Drug: Placebo (for Varlitinib)
17 Recruiting Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Conditions: Colorectal Neoplasms;   Gastric Neoplasms;   Cholangiocarcinoma;   Bile Duct Cancer;   Pancreas Cancer
Intervention:
18 Not yet recruiting Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer
Conditions: Adenocarcinoma Metastatic;   Biliary Tract Cancer;   Adenocarcinoma of the Biliary Tract;   Adenocarinoma Locally Advanced;   Non-Resectable Hepatocellular Carcinoma;   Intrahepatic Bile Duct Carcinoma;   Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Arm NaI-IRI + 5-FU + Leucovorin (Arm A);   Drug: Arm Cisplatin + Gemcitabine (Arm B)
19 Recruiting T-EUS for Gastrointestinal Disorders: A Multicenter Registry
Conditions: Cholangiocarcinoma;   Pancreatic Cancer;   Bile Duct Cancer;   Biliary Stricture;   Biliary Obstruction;   Stent Obstruction;   Proximal Duct Stricture;   Distal Duct Stricture;   Ampullary Cancer;   Biliary Sphincter Stenosis;   Impacted Stones;   Chronic Pancreatitis;   Peri-ampullary Diverticula;   Altered Anatomy
Intervention: Procedure: EUS guided ERCP
20 Recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Conditions: Breast Cancer;   Colon Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastrointestinal Cancer;   Liver and Intrahepatic Biliary Tract Cancer;   Lung Cancer;   Metastatic Cancer;   Pancreatic Cancer;   Rectal Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: Cu 64 anti-CEA monoclonal antibody M5A IV

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.